At MAD-ID 2025, Dakota Rorie, PharmD, highlights cost and access barriers to uptake of preferred CDI therapy.
Dakota Rorie, PharmD
Advertisement
PGY-2 Pharmacotherapy Resident at the Medical University of South Carolina.
Articles by Dakota Rorie, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Top Infectious Disease News Stories Week of October 11-October 17
2
Invivyd Announces FDA Clearance of IND Application for VYD2311 and Advancement of REVOLUTION Clinical Program
3
ViiV Healthcare Announces 96-Week PASO DOBLE Results Showing Dovato as Effective as Biktarvy in Maintaining Viral Suppression
4
